NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Biotechnology · USD

ETHZilla Corporation (ETHZ) Stock Analysis

ETHZilla Corporation (ETHZ) is a Biotechnology stock listed on NASDAQ and quoted in US Dollar.

ETHZ

$5.85

+$0.39 (+7.24%)

Last trade May 1, 2026

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ETHZ with… →

ETHZ Key Statistics

As of May 1, 2026
Trading
Open
$5.50
Previous Close
$5.46
Day's Range
5.36–5.87
52-Week Range
2.99–174.60
Volume
728.14K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.14
Valuation
Market Cap
$68.63M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
16.70
EPS (ttm)Profit attributable to each share over the last twelve months.
−182.51
Financials (FY)
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
1-Year Return
−56.02%
Dividend and dates
Avg Volume
789.88K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ETHZ Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+19.39%
2025−73.08%
2024 (partial year)−6.19%

As of May 1, 2026.

ETHZ Valuation vs Biotechnology Median

Median of 656 stocks
MetricETHZBiotechnology medianvs median
P/S ratio16.7015.269% above
Profit margin0.00%0.00%0.0 pts above

Medians across 656 Biotechnology stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

ETHZilla Corporation (ETHZ) is capitalised at $68.63M on the latest close. It is classified in the Biotechnology industry, within the Healthcare sector.

ETHZ last closed at $5.85 on May 1, 2026. That is +$0.39 (+7.24%) against the previous close. Over the past 52 weeks the price has ranged from $2.99 to $174.60. The latest close sits 95.65% above that 52-week low.

Financial Health

Trailing twelve-month revenue on file is $4.11M. The reported profit margin is 0%. Trailing earnings per share are −182.51.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 16.7. On price-to-sales that is 9.4% above the Biotechnology median of 15.26. 656 Biotechnology companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −56.02%. Beta against the wider market is reported at 1.14. Daily returns over the trailing 1 year annualize to a volatility of 280.51%.

Growth & Income

The record shows no dividend for ETHZ.

So far in 2026 the price is +19.39%. The record holds one complete calendar year, 2025, which returned −73.08%.

Peer Comparison

ETHZilla Corporation (ETHZ) operates in the Biotechnology industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
ETHZilla Corporation ETHZ $68.63M —
Vertex Pharmaceuticals Incorporated VRTX $138.42B 32.5
Regeneron Pharmaceuticals, Inc. REGN $85.22B 20.5
argenx SE ARGX $64.25B 40.1

The Biotechnology industry average P/E ratio is 12.6x. ETHZilla Corporation has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of May 1, 2026.

Related Biotechnology Stocks

VRTX

Vertex Pharmaceuticals Incorporated

$138.42B

 REGN

Regeneron Pharmaceuticals, Inc.

$85.22B

 ARGX

argenx SE

$64.25B

 MRNA

Moderna, Inc.

$58.11B

 RVMD

Revolution Medicines, Inc.

$45.01B

 ONC

BeOne Medicines AG

$40.53B
View all Biotechnology stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About ETHZilla Corporation

ETHZilla Corporation operates a technology company focused on Ethereum-based infrastructure for the tokenization of real-world assets. The company develops platforms that enable the conversion of illiquid, institutional-grade assets into blockchain-based financial instruments using Ethereum Layer 2 protocols. It bridges traditional finance and blockchain technology by supporting regulated access, scalability, and efficiency in asset tokenization. The company was formerly known as 180 Life Sciences Corp. and changed its name to ETHZilla Corporation in August 2025. ETHZilla Corporation is headquartered in Palm Beach, Florida.

Visit website →